Literature DB >> 24076142

Determination of allelic expression of SNP rs1880676 in choline acetyltransferase gene in HeLa cells.

Zhongli Yang1, Chen Lin, Shaolin Wang, Chamindi Seneviratne, Jundong Wang, Ming D Li.   

Abstract

Recently, we reported that several polymorphisms and haplotypes in the choline acetyltransferase gene (ChAT) are associated with nicotine dependence (ND). Of them, SNP rs1880676 is of particular interest because: (1) it is a non-synonymous variant located in the coding region of an alternatively spliced form of ChAT and (2) it is located in several haplotypes that are significantly associated with ND. The objective of this study was to determine, using an in vitro system, whether the alleles G (coding for aspartic acid) or A (coding for asparagine) of rs1880676 have any allele-specific effect on ChAT expression. We first used site-directed mutagenesis to construct two expression vectors differed in the allelic position of rs1880676 (G/A), which were transfected into HeLa cells. We then measured expression of ChAT associated with each allele. We found significant expression differences for the two alleles, with the G allele being expressed significantly greater than A allele (P<0.01 at both mRNA and protein levels). Further, we validated the ChAT expression of the G allele was significantly higher than that of the A allele by using ELISA assay (P=0.00016). We concluded that rs1880676 is functional and that the allelic variations of this polymorphism are involved in developing ND by altering ChAT expression.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Choline acetyltransferase; Expression; HeLa cells; rs1880676

Mesh:

Substances:

Year:  2013        PMID: 24076142      PMCID: PMC3836665          DOI: 10.1016/j.neulet.2013.09.040

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  26 in total

1.  A predicted cortical serotonergic/cholinergic/GABAergic interface as a site of pathology in schizophrenia.

Authors:  B Dean
Journal:  Clin Exp Pharmacol Physiol       Date:  2001 Jan-Feb       Impact factor: 2.557

Review 2.  A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins.

Authors:  Ming D Li; Rong Cheng; Jennie Z Ma; Gary E Swan
Journal:  Addiction       Date:  2003-01       Impact factor: 6.526

Review 3.  Actual causes of death in the United States, 2000.

Authors:  Ali H Mokdad; James S Marks; Donna F Stroup; Julie L Gerberding
Journal:  JAMA       Date:  2004-03-10       Impact factor: 56.272

Review 4.  Interactions between histaminergic and cholinergic systems in learning and memory.

Authors:  L Bacciottini; M B Passani; P F Mannaioni; P Blandina
Journal:  Behav Brain Res       Date:  2001-10-15       Impact factor: 3.332

5.  Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.

Authors:  P Davies
Journal:  Brain Res       Date:  1979-08-03       Impact factor: 3.252

6.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies.

Authors:  R Peto; S Darby; H Deo; P Silcocks; E Whitley; R Doll
Journal:  BMJ       Date:  2000-08-05

Review 7.  Nicotine addiction: the possible role of functional upregulation.

Authors:  Bruno Buisson; Daniel Bertrand
Journal:  Trends Pharmacol Sci       Date:  2002-03       Impact factor: 14.819

Review 8.  The genetic epidemiology of smoking.

Authors:  P F Sullivan; K S Kendler
Journal:  Nicotine Tob Res       Date:  1999       Impact factor: 4.244

9.  Structural insights and functional implications of choline acetyltransferase.

Authors:  Lakshmanan Govindasamy; Brenda Pedersen; Wei Lian; Thomas Kukar; Yunrong Gu; Shouguang Jin; Mavis Agbandje-McKenna; Donghai Wu; Robert McKenna
Journal:  J Struct Biol       Date:  2004-11       Impact factor: 2.867

10.  Changes in brain cholinesterases in senile dementia of Alzheimer type.

Authors:  E K Perry; R H Perry; G Blessed; B E Tomlinson
Journal:  Neuropathol Appl Neurobiol       Date:  1978 Jul-Aug       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.